Thursday , November 14 2019
Home / colombia / They removed lots of jarabe in Colombia for the presence of “probablemente carcinogenic” substance

They removed lots of jarabe in Colombia for the presence of “probablemente carcinogenic” substance

The Invima announced that the company GlaxoSmithKline Colombia S. The voluntary removal of the lots by the possible presence of nitrosodimethylamine, a compound that is also found in a tobacco.

Colombia and Zantac are distributed by the company GlaxoSmithKline.Pexels -Angelica

A couple of weeks ago, the National Institute for Food and Drug Surveillance (Invima) published a brief health alert. On three pages I reported that a known jarabe had been withdrawn from the market because it had a support classified as “probably carcinogenic” by the International Agency for Cancer Research (IARC). (Lea Vuelve the intense discussion for the high price of medicines against hepatitis C)

Zantac, as traded in Colombia, was withdrawn by the company GlaxoSmithKline Colombia S.A., the company holding the health registration. Its active ingredient is Ranitidine, used to treat gastric problems or acidity. (Lea Una hormone not authorized for weight loss)

“The investor informs that the company GlaxoSmithKline Colombia S.A. has begun the voluntary withdrawal of lots 1728200002 and 1726100008 (last manufactured and distributed before expiration of the Sanitary Registration in December 2018), the corresponding items in the Zantac product jarabe ”, signs the sanitary entity.

In the end a little more detailed, which is why this product was removed, because it possibly contained a so-called nitrosodimethylamine (NDMA) support. This is a device that, as explained by Invima, can be found in a tobacco, processed foods and some oil articles.

At the moment, the institute says, a check is being made in Colombia on the suppliers of raw material for ranitidine products, with the purpose of evaluating the presence of NDMA.

For the moment, your recommendation to those in charge of health is to inform immediately if you know of places from which the Zantac of the withdrawn lots is being distributed.

“If you consume Zantac management with its product supplier and product exchange. Do not stop the medicine without waking up before your doctor treating a treatment, "comes the Invima a la población.

The Food and Drug Administration of the United States and agencies in Canada, France and Spain are some of the entities that have also withdrawn their markets from the presence of NDMA.


2019-10-21T19: 41: 20-05: 00


2019-10-21T19: 41: 20-05: 00



– Healthy Writing


They removed lots of jarabe in Colombia for the presence of “probablemente carcinogenic” substance




Source link